Clinical Trial Update: Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine [Phase 2]

View source ↗

Summary

Phase 2 trial completion update on using N-acetylcysteine to prevent drug-induced ototoxicity in peritoneal dialysis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sensorineural Hearing Loss

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: TC Erciyes University | Conditions: Drug-induced Ototoxicity in Peritoneal Dialysis Patients | Phase 2 | Status: COMPLETED